Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives.

Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K. Source Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Johann Wolfgang Goethe-University, Heinrich-Hoffmann-Str. 10, 60528 Frankfurt/Main, Germany. harald.hampel@med.uni-frankfurt.de Abstract Advances in therapeutic strategies for Alzheimer’s disease that lead(…)